1. What Is the Single Cell Sequencing Market?
The Single Cell Sequencing Market covers technologies profiling genomic, transcriptomic, and proteomic information from individual cells to reveal cellular heterogeneity, rare cell types, and state transitions. Single cell sequencing encompasses scRNA-seq, scATAC-seq, CITE-seq, single-cell whole genome, and single-cell multiomics platforms. Market dynamics reflect single-cell RNA sequencing becoming a standard oncology research tool, Human Cell Atlas project driving adoption at scale, and clinical translation of single-cell liquid biopsy.
2. Single Cell Sequencing Market Size & Forecast
3. Emerging Technologies
- Multiomics single-cell platforms simultaneously profiling RNA and protein from the same cell are advancing. Growing adoption is driven by comprehensive cell state characterisation requirements beyond single modality.
- Clinical single-cell liquid biopsy detecting rare circulating tumour cell from blood draw are advancing. Growing adoption is driven by minimally invasive cancer monitoring and treatment response requirements.
- Automated single-cell library preparation reducing technician hands-on time from 8 to 1 hour are advancing. Growing adoption is driven by core facility throughput improvement requirements.
- Single-cell spatial transcriptomics combining spatial position with single-cell resolution are advancing. Growing adoption is driven by tissue architecture and cell identity integration research requirements.
Such innovations are driving change across adjacent industries too. Discover more in our Spatial Biology Market.
4. Key Market Opportunity
Revenue is concentrated in the Single Cell Sequencing Market at the oncology tumour heterogeneity research sub-market, where cancer cell subpopulation characterisation drives the highest research investment. Immunology single-cell creates a drug target validation opportunity as immune cell state profiling enables checkpoint therapy patient stratification. Clinical translation creates a diagnostic opportunity as single-cell liquid biopsy approaches clinical validation. Asia Pacific single cell sequencing creates geographic expansion as Chinese, South Korean, and Japanese research institution and biotech investment grows.
5. Top Companies in the Single Cell Sequencing Market
The following organisations hold leading positions in the Single Cell Sequencing Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- 10x Genomics (Chromium, Xenium)
- Illumina (NovaSeq)
- Pacific Biosciences (Revio)
- Bio-Rad (Single-Cell)
- BD Biosciences (Rhapsody)
- Parse Biosciences (SPLIT-seq)
- Scale Biosciences (Combinatorial)
- Mission Bio (Tapestri)
- Fluidigm (C1)
- Miltenyi (Single Cell)
6. Market Segmentation
The Single Cell Sequencing Market is analysed across 3 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | scRNA-seq scATAC-seq CITE-seq Single-Cell WGS Multiomics |
| By Application | Oncology Immunology Neuroscience Developmental Biology Drug Discovery |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Single Cell Sequencing Market trajectory over the forecast period:
Ten x Genomics Chromium Achieves 70 Percent Single Cell Sequencing Market Share.Ten x Genomics Chromium single-cell controller achieving 70 percent global single-cell sequencing market share in 2024 demonstrates commercial single-cell platform dominance. Ten x Genomics achieving 2 million cells profiled per customer per year on average demonstrates the research throughput enabling atlas-scale single-cell biology.
Illumina and Pacific Biosciences Achieve Single-Cell Long-Read Sequencing Platform Leadership.Illumina Novaseq and Pacific Biosciences Revio achieving single-cell long-read application sequencing commercial deployment in 2024 demonstrate sequencing platform company single-cell analysis leadership. PacBio Revio achieving 360 GB per day at single-cell cDNA resolution demonstrates long-read capability enabling full-length transcript isoform single-cell analysis.
Human Cell Atlas Project Achieves 30 Million Single Cell Profiles From 50 Tissue Types.Human Cell Atlas project achieving 30 million human cell profiles from 50 tissue types across 70 research institutions in 2024 demonstrates single-cell biology at the largest coordinated biological mapping project. Human Cell Atlas achieving cell type atlas for lung, kidney, and brain demonstrates the reference resource enabling disease research.
For related market intelligence, see the Digital Pathology Market.
8. Segmental Analysis
By technology, the scRNA-seq Gene Expression segment dominated the Single Cell Sequencing Market in 2025. Representing the largest revenue category as 10x Chromium scRNA-seq drives the majority of single-cell research investment. The Multiomics Simultaneous Profiling segment is the fastest-growing category, advancing as CITE-seq and joint profiling platforms achieve academic and pharma adoption.
By application, Oncology dominated in 2025, while Drug Discovery is registering the highest single-cell sequencing investment growth rate.
9. Regional Analysis
Regional demand patterns across the Single Cell Sequencing Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Single Cell Sequencing Market in 2025, holding 49.7% of the global market. Academic research institutions, biopharmaceutical companies, and translational medicine programmes are deploying single cell sequencing platforms for cell type characterisation, tumour heterogeneity analysis, and developmental biology research at single-cell resolution. NIH Human Cell Atlas project investment and growing pharmaceutical investment in single-cell sequencing for immunology and oncology drug discovery are encouraging platform adoption. Strong life sciences research infrastructure, established genomics sequencing market, and high academic research investment are generating dominant regional single cell sequencing demand.
Highest CAGR Region
Europe is expected to register the highest CAGR of 38.22% during the forecast period. Academic research institutions, pharmaceutical companies, and life sciences technology companies across Germany, the United Kingdom, Switzerland, Sweden, and the Netherlands are deploying single cell sequencing platforms for cancer biology, immunology, and developmental science research. European research funding, growing pharmaceutical investment in single-cell biology for drug target identification, and strong European academic research ecosystem are encouraging single cell sequencing adoption. Rising academic and commercial research investment in single-cell biology for precision medicine, immunology, and developmental science applications are generating strong European demand for single cell sequencing platforms.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Single Cell Sequencing Market was valued at USD 2.47 Bn in 2025 and is projected to reach USD 22.67 Bn by 2034, growing at a CAGR of 27.9% over the 2026–2034 forecast period.
The Single Cell Sequencing Market is projected to grow at a CAGR of 27.9% from 2026 to 2034.
North America accounted for the largest share of the Single Cell Sequencing Market in 2025, holding 49.7% of the global market.
The leading companies in the Single Cell Sequencing Market include 10x Genomics (Chromium, Xenium), Illumina (NovaSeq), Pacific Biosciences (Revio), Bio-Rad (Single-Cell), BD Biosciences (Rhapsody), Parse Biosciences (SPLIT-seq), Scale Biosciences (Combinatorial), Mission Bio (Tapestri), Fluidigm (C1), Miltenyi (Single Cell).
Ten x genomics chromium achieves 70 percent single cell sequencing market share.
By technology, the scRNA-seq Gene Expression segment dominated the Single Cell Sequencing Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.